SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Biotechnology Cancer Cures

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (120)10/23/1999 10:50:00 PM
From: tnsaf  Read Replies (1) of 226
 
An interesting site with a Medical News Alert section: pslgroup.com.

Trial Is First To Activate Entire Human
Immune System Against Prostate Cancer

BETHESDA, MD -- October 20, 1999 -- Johns Hopkins cancer
researchers report the successful use of human gene therapy to
activate the human immune system against metastatic prostate
cancer. The achievement, believed to be a first, could have
implications in the treatment of many kinds of cancer. The study
results are published in the October 15, 1999* issue of Cancer
Research.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext